Review decision date: February 2014

Review decision: 

Following consultation with stakeholders this guideline has now been placed on the static list.

Next review date: TBC

This clinical guideline offers evidence-based advice on the care and treatment of adults having ablative therapy to treat Barrett’s oesophagus with high-grade dysplasia or with intramucosal cancer. It is the full guideline and contains all the recommendations, details of how they were developed, and reviews of the evidence they were based on. Barrett’s oesophagus develops when stomach acid or bile repeatedly leaks upwards and damages the lining of the oesophagus.

This guideline was previously called Barrett's oesophagus: Ablative therapy for the treatment of Barrett's oesophagus.

  • National Institute for Health and Care Excellence (NICE) accreditation logo